undamentalytics Newsletter

Seastar Medical Holding Corp income statement

In fiscal 2025, Seastar Medical Holding Corp reported revenue of $1.2m, up 814.1% on the year before, operating income of −$12.2m (a -986.6% margin) and net income of −$12.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Seastar Medical Holding Corp: income statement, annual
Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0012
Cost of revenue0000
Gross profit0012
Research and development6989
General and administrative8967
Operating income−14−18−12−14
Interest expense1000
Income before tax−26−25−12−14
Income tax0000
Net income−26−25−12−14
Diluted EPS−$30.26−$6.63——
Diluted shares (average)—4m2m—

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ICU vs IMDXFEMY vs ICUICU vs VNRXICU vs PLSE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Seastar Medical Holding Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Seastar Medical Holding Corp.